Gynecology : BC Cancer Agency

Agency Links:

Home

Compliments & Complaints

Help

Site Map

BC Cancer Agency >> Health Professionals Info >> Chemotherapy Protocols >> Gynecology


Chemotherapy Protocols
	Gynecology

Gynecology

Print this Page

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm.

See Ovarian treatments
See Cervical treatments
See Endometrial treatments
See Other treatments

Please note: All links in the tables below open PDF documents.

Ovarian Treatments
Protocol Code and Description	Available documents (revision date indicated in red)
GOBEP: Therapy of non-dysgerminomatous ovarian germ cell cancer using Bleomycin, Etoposide and Cisplatin.	- Protocol (29 Jun 2011) - Preprinted Order (29 Jun 2011) - Patient handout (01 Feb 2011)
GOEP: Therapy of Dysgerminomatous Ovarian Germ Cell Cancer Using Cisplatin and Etoposide.	- Protocol (29 Jun 2011) - Preprinted Order (29 Jun 2011)
GOOVAI: Therapy for Advanced Ovarian Cancer using an Aromatase Inhibitor.	- Protocol (01 Jan 2012) - Preprinted Order (01 Jan 2012)
GOOVCADM: Primary Treatment of Invasive Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer, with no Visible Residual Tumour (Moderate-High Risk) Using Carboplatin and Docetaxel.	- Protocol (01 Apr 2011) - Preprinted order (29 Jun 2011)
GOOVCADR: Second Line Treatment Using Docetaxel and Carboplatin for Epithelial Ovarian Cancer Relapsing after Primary Treatment.	- Protocol (01 Sep 2011) - Preprinted order (29 Jun 2011)
GOOVCADX: Primary Treatment of Visible Residual (Extreme Risk) Invasive Epithelial Ovarian Cancer Using Carboplatin and Docetaxel.	- Protocol (01 Apr 2011) - Preprinted order (29 Jun 2011)
GOOVCAG: Treatment of Advanced Ovarian Cancer in Patients Who Have Progressed or Recurred Following First-line Platinum-based Treatment Using Carboplatin and Gemcitabine.	- Protocol (01 Mar 2012) - Preprinted order (01 Apr 2012)
GOOVCARB: First or Second Line Therapy for Invasive Epithelial Ovarian Cancer using Single-Agent Carboplatin.	- Protocol (01 Mar 2012) - Preprinted order (27 Jun 2011)
GOOVCATM: Primary treatment of invasive epithelial ovarian, fallopian tube and primary peritoneal cancer, with no visible residual tumour (moderate-high risk) using Carboplatin and Paclitaxel.	- Protocol (01 Apr 2011) - Preprinted order (27 Jun 2011) - Patient Handout (04 Jul 2011)
GOOVCATR: Second line treatment using paclitaxel and carboplatin for epithelial ovarian cancer relapsing after primary treatment.	- Protocol (01 Apr 2011) - Preprinted order (29 Jun 2011) - Patient Handout (04 Jul 2011)
GOOVCATX: Primary treatment of visible residual (extreme risk) invasive epithelial ovarian cancer in ambulatory care settings using Paclitaxel and Carboplatin.	- Protocol (01 Mar 2012) - Preprinted order (27 Jun 2011) - Patient Handout (04 Jul 2011)
GOOVCIS: Therapy for Invasive Epithelial Ovarian Cancer using Cisplatin	- Protocol (04 Jul 2011) - Preprinted order (27 Jun 2011) - Patient handout (01 Mar 2010)
UGOOVDDCAT: Treatment Of Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Carboplatin and Weekly Paclitaxel.	- Protocol (01 May 2012) - Preprinted order (01 May 2012)
GOOVDOC: Treatment Of Progressive, Platinum-Refractory Epithelial Ovarian Carcinoma, Primary Peritoneal Carcinoma Or Fallopian Tube Carcinoma Using Docetaxel.	- Protocol (01 Sep 2010) - Preprinted order (29 Jun 2011)
GOOVETO: Treatment of Relapsed/Progressing Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma Using Etoposide	- Protocol (01 Mar 2012) - Preprinted order (27 Jun 2011)
GOOVGEM: Palliative chemotherapy for re-treatment of ovarian, tubal, and peritoneal cancer using gemcitabine.	- Protocol (01 Mar 2012) - Preprinted order (27 Jun 2011)
GOOVIPPC: BCCA Protocol Summary for Primary Treatment of Stage III less than or equal to 1 cm Visible Residual Invasive Epithelial Ovarian Cancer or Stage 1 Grade 3 or Stage II Grade 3 Papillary Serious Ovarian Cancer Using Intravenous and Intraperitoneal Paclitaxel and Intraperitoneal Carboplatin	- Protocol (01 May 2012) - Preprinted order (01 May 2012) - Patient handout (01 Oct 2007)
GOOVLDOX: Treatment of Relapsed/Progressing, Epithelial Ovarian, Primary Peritoneal Or Fallopian Tube Carcinoma Using Pegylated Liposomal Doxorubicin	- Protocol (27 Jun 2011) - Preprinted order (01 Dec 2011) - Patient handout (01 Aug 2007)
GOOVPLDC: Second line treatment for Epithelial Ovarian Cancer Relapsing after primary treatment using Pegylated Liposomal Doxorubicin (PLD) and Carboplatin	- Protocol (01 Sep 2011) - Preprinted order (04 Jul 2011) - Patient Handout (04 Jul 2011)
GOOVTAX3: Treatment of progressive, platinum-refractory epithelial ovarian carcinoma, primary peritoneal carcinoma or fallopian tube carcinoma using paclitaxel.	- Protocol (01 Mar 2012) - Preprinted order (27 Jun 2011)
GOOVTOP: Treatment of relapsed/progressive epithelial ovarian, fallopian tube or primary peritoneal cancer using Topotecan.	- Protocol (01 Mar 2012) - Preprinted order (29 Jun 2011)
GOOVVIN: Palliative Chemotherapy for Re-treatment of Ovarian, Tubal, and Peritoneal Cancer Using Vinorelbine.	- Protocol (01 Mar 2012) - Preprinted order (29 Jun 2011)

Cervical Treatments
Protocol Code and Description	Available Documents (revision date indicated in red)
GOCXCAD: Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with Carboplatin and Docetaxel in Ambulatory Care Settings.	- Protocol (01 Apr 2011) - Preprinted order (29 Jun 2011)
GOCXCAT: Primary Treatment of Advanced/Recurrent Non-Small Cell Cancer of the Cervix with Carboplatin and Paclitaxel in Ambulatory Care Settings.	- Protocol (01 Apr 2011) - Preprinted order (27 Jun 2011)
GOCXCRT: Treatment of High Risk Squamous Carcinoma, Adenocarcinoma, or Adenosquamous Carcinoma of the Cervix with Concurrent Cisplatin and Radiation.	- Protocol (27 Jun 2011) - Preprinted order (27 Jun 2011)

Endometrial Treatments
Protocol Code and Description	Available documents (revision date indicated in red
GOENDAI: Advanced Therapy for Endometrial Cancer using an Aromatase Inhibitor	- Protocol (01 Apr 2010) - Preprinted order (01 Sep 2010)
GOENDCAD: Treatment of Primarily Advanced or Recurrent Endometrial Cancer using Carboplatin and Docetaxel	- Protocol (01 Apr 2011) - Preprinted order (29 Jun 2011)
GOENDCAT: Treatment of Primary Advanced or Recurrent Endometrial Cancer using Carboplatin and Paclitaxel	- Protocol (01 Apr 2011) - Preprinted order (27 Jun 2011) - Patient Handout (04 July 2011)
GOENDH: Non-Aromatase Inhibitor Hormonal Treatment of Endometrial Cancer	- Protocol (01 May 2012) - Preprinted order (01 May 2012)

Others
Protocol Code and Description	Available documents (revision date indicated in red
GOSADG: Treatment of Uterine Sarcoma Cancer using Docetaxel and Gemcitabine	- Protocol (29 Jun 2011) - Preprinted order (29 Jun 2011)
GOSMCCRT: Treatment of Small Cell or Neuroendocrine Carcinoma of Gynecologic System Origin using Paclitaxel, Cisplatin, Etoposide and Carboplatin with Radiation	- Protocol (29 Jun 2011) - GOSMCCRT(c) Preprinted order (29 Jun 2011) - GOSMCCRT(d) Preprinted order (29 Jun 2011) - GOSMCCRT(e) Preprinted order (29 Jun 2011)
GOTDHR: Therapy for high risk gestational trophoblastic (GO9103) "MACE" using Cisplatin, Etoposide, Actinomycin D. Methotrexate and Leucovorin.	- Protocol (01 May 2009)
GOTDLR: Therapy for low risk gestational trophoblastic neoplasia (GO 94 02) using Methotrexate, Leucovorin and Actinomycin D.	- Protocol (22 Feb 2012)